Company: RGNX
Filing Date: 2025-06-03
Form Type: 8-K
Source: 0000950170-25-080986
Chunk: 0

Company: REGENXBIO Inc.
Filing Date: 2025-06-03
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

REGENXBIO Inc. (the “ Company”) held its 2025 Annual Meeting of Stockholders on May 30, 2025 (the “ Annual Meeting”). There were 41,282,389 shares of common stock represented at the meeting by valid proxies or voted at the meeting, which was approximately 82.4% of the shares of common stock that were entitled to vote at the Annual Meeting. The final voting results for each proposal considered at the Annual Meeting are set forth below. For more information on the proposals, please refer to the Company’s definitive proxy statement related to the Annual Meeting, which was filed with the SEC on April 8, 2025 (the “ Proxy Statement”).

Proposal 1: By the following vote, the following four persons were elected to serve as Class I directors until the Company’s 2028 annual meeting of stockholders:

  Nominee                            Votes For      Votes Withheld      Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────────────────────────
  Allan Fox                         27,990,560           6,436,985             6,854,844  
  Alexandra Glucksmann, Ph. D.      29,264,825           5,162,720             6,854,844  
  Curran Simpson                    32,802,148           1,625,397             6,854,844  
  Jennifer Zachary                  29,179,798           5,247,747             6,854,844  

Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025:

   Votes For      Votes Against      Votes Abstaining      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────
  41,172,522             39,375                70,492                     0  

Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement:

   Votes For      Votes Against      Votes Abstaining      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────
  32,577,603          1,756,155